Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Scand J Med Sci Sports ; 33(11): 2094-2109, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37449413

ABSTRACT

BACKGROUND: Sudden cardiac death (SCD) is the leading medical cause of death in athletes. To prevent SCD, screening for high-risk cardiovascular conditions (HRCC) is recommended. Screening strategies are based on a limited number of studies and expert consensus. However, evidence and efficacy of athlete HRCC screening is unclear. OBJECTIVE: To determine methodological quality and quality of evidence of athlete screening, and screening efficacy to detect HRCC in a systematic review. METHODS: We performed a systematic search of Medline, Embase, Scopus and Cochrane Library up to June 2021. We included articles containing original data of athlete cardiovascular screening, providing details of screening strategies, test results and HRCC detection. We assessed methodological quality of the included articles by QUADAS-2, quality of evidence of athlete HRCC screening by GRADE, and athlete HRCC screening efficacy by SWiM. RESULTS: Of 2720 citations, we included 33 articles (1991-2018), comprising 82 417 athletes (26.7% elite, 73.4% competitive, 21.7% women, 75.2% aged ≤35). Methodological quality was 'very low' (33 articles), caused by absence of data blinding and inappropriate statistical analysis. Quality of evidence was 'very low' (33 articles), due to observational designs and population heterogeneity. Screening efficacy could not be reliably established. The prevalence of HRCC was 0.43% with false positive rate (FPR) 13.0%. CONCLUSIONS: Methodological quality and quality of evidence on athlete screening are suboptimal. Efficacy could not be reliably established. The prevalence of screen detected HRCC was very low and FPR high. Given the limitations of the evidence, individual recommendations need to be prudent.

2.
Mayo Clin Proc Innov Qual Outcomes ; 6(6): 525-535, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36267910

ABSTRACT

Objective: To systematically investigate and document the infrastructure, practices, recommendations, and clinical consequences of a structured, organized sports cardiology multidisciplinary team (MDT) for athletes and patients who wish to engage in sports and exercise. Patients and Methods: We established bimonthly sports cardiology MDT meetings, with a permanent panel of experts in sports cardiology, genetics, pediatric cardiology, cardiovascular imaging, electrophysiology, and sports and exercise medicine. Cases were referred nationally or internationally by cardiologists/sports physicians. We retrospectively analyzed all MDT cases (April 10, 2019 through May 13, 2020) and collected clinical follow-up data up to 1 year after the initial review. Results: A total of 115 athletes underwent MDT review; of them, 11% were women, 65% were recreational athletes, and 54% were performing "mixed" type of sports; the mean age was 32±16 years. An MDT review led to a diagnosis revision of "suspected cardiac pathology" to "no cardiac pathology" in 38% of the athletes and increased the number of definitive diagnoses (from 77 to 109; P=.03). We observed fewer "total sports restrictions" (from 6 to 0; P=.04) and more tailored sports advice concerning "no peak load/specific maximum load" (from 10 to 26; P=.02). At the 14±6-month follow-up, 112 (97%) athletes reported no cardiovascular events, 111 (97%) athletes reported no (new) cardiac symptoms, 113 (98%) athletes reported adherence to the MDT sports advice, and no diagnoses were revised. Conclusion: Our experiences with a comprehensive sports cardiology MDT demonstrate that this approach leads to higher percentages of definitive diagnoses and fewer cardiac pathology diagnoses, more tailored sports advice with excellent rates of adherence, and fewer total sports restrictions. Our findings highlight the added value of sports cardiology MDTs for patient and athlete care.

3.
Sports Med Open ; 7(1): 50, 2021 Jul 22.
Article in English | MEDLINE | ID: mdl-34292409

ABSTRACT

BACKGROUND: Sudden cardiac arrest (SCA) during sports can be the first symptom of yet undetected cardiovascular conditions. Immediate chest compressions and early defibrillation offer SCA victims the best chance of survival, which requires prompt bystander cardiopulmonary resuscitation (CPR). AIMS: To determine the effect of rapid bystander CPR to SCA during sports by searching for and analyzing videos of these SCA/SCD events from the internet. METHODS: We searched images.google.com , video.google.com , and YouTube.com , and included any camera-witnessed non-traumatic SCA during sports. The rapidity of starting bystander chest compressions and defibrillation was classified as < 3, 3-5, or > 5 min. RESULTS: We identified and included 29 victims of average age 27.6 ± 8.5 years. Twenty-eight were males, 23 performed at an elite level, and 18 participated in soccer. Bystander CPR < 3 min (7/29) or 3-5 min (1/29) and defibrillation < 3 min was associated with 100% survival. Not performing chest compressions and defibrillation was associated with death (14/29), and > 5 min delay of intervention with worse outcome (death 4/29, severe neurologic dysfunction 1/29). CONCLUSIONS: Analysis of internet videos showed that immediate bystander CPR to non-traumatic SCA during sports was associated with improved survival. This suggests that immediate chest compressions and early defibrillation are crucially important in SCA during sport, as they are in other settings. Optimal use of both will most likely result in survival. Most videos showing recent events did not show an improvement in the proportion of athletes who received early resuscitation, suggesting that the problem of cardiac arrest during sports activity is poorly recognized.

4.
Eur J Prev Cardiol ; 28(14): 1569-1578, 2021 12 20.
Article in English | MEDLINE | ID: mdl-33846742

ABSTRACT

This article provides an overview of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology on sports participation in individuals with valvular heart disease (VHD). The aim of these recommendations is to encourage regular physical activity including sports participation, with reasonable precaution to ensure a high level of safety for all affected individuals. Valvular heart disease is usually an age-related degenerative process, predominantly affecting individuals in their fifth decade and onwards. However, there is an increasing group of younger individuals with valvular defects. The diagnosis of cardiac disorders during routine cardiac examination often raises questions about on-going participation in competitive sport with a high dynamic or static component and the level of permissible physical effort during recreational exercise. Although the natural history of several valvular diseases has been reported in the general population, little is known about the potential influence of chronic intensive physical activity on valve function, left ventricular remodelling pulmonary artery pressure, and risk of arrhythmia. Due to the sparsity of data on the effects of exercise on VHD, the present document is largely based on clinical experience and expert opinion.


Subject(s)
Cardiology , Heart Valve Diseases , Sports , Athletes , Exercise , Heart Valve Diseases/epidemiology , Humans
5.
Eur J Prev Cardiol ; 27(14): 1529-1538, 2020 09.
Article in English | MEDLINE | ID: mdl-31996014

ABSTRACT

OBJECTIVE: Structured electrocardiography (ECG) analysis is used to screen athletes for high-risk cardiovascular conditions (HRCC) to prevent sudden cardiac death. ECG criteria have been specified and recommended for use in young athletes ≤ 35 years. However, it is unclear whether these ECG criteria can also be applied to master athletes >35 years. AIM: The purpose of this study was to test whether the existing ECG criteria for detecting HRCC in young athletes can be applied to master athletes. METHODS: We conducted a cross-sectional study among athletes >35 years screened for HRCC between 2006 and 2010. We performed a blinded retrospective analysis of master athletes' ECGs, separately applying European Society of Cardiology (ESC)-2005, Seattle, and International criteria. HRCC were defined using recommendations from the international cardiac societies American Heart Association and American College of Cardiology, and ESC, based on ECG screening and cardiovascular evaluation (CVE). RESULTS: We included 2578 master athletes in the study, of whom 494 had initial screening abnormalities mandating CVE. Atrial enlargement (109, 4.1%) and left ventricular hypertrophy (98, 3.8%) were the most common ECG abnormalities found using the ESC-2005 or Seattle criteria. Applying the International criteria, ST-segment deviation (66, 2.6%), and T-wave inversion (58, 2.2%) were most frequent. The ESC-2005 criteria detected more HRCC (46, 1.8%) compared with the Seattle (36, 1.4%) and International criteria (33, 1.3%). The most frequently detected HRCC was coronary artery disease (24, 0.9%). CONCLUSION: ECG criteria recommended for use in young athletes can be applied to master athletes' ECGs to detect HRCC. The ESC-2005 criteria had the highest sensitivity for detecting HRCC among master athletes.


Subject(s)
Athletes , Cardiovascular Diseases/diagnosis , Electrocardiography/methods , Mass Screening/methods , Adult , Cardiovascular Diseases/physiopathology , Cross-Sectional Studies , Female , Follow-Up Studies , Humans , Male , Retrospective Studies
7.
Eur Heart J ; 40(1): 19-33, 2019 01 01.
Article in English | MEDLINE | ID: mdl-30561613

ABSTRACT

Myocardial diseases are associated with an increased risk of potentially fatal cardiac arrhythmias and sudden cardiac death/cardiac arrest during exercise, including hypertrophic cardiomyopathy, dilated cardiomyopathy, left ventricular non-compaction, arrhythmogenic cardiomyopathy, and myo-pericarditis. Practicing cardiologists and sport physicians are required to identify high-risk individuals harbouring these cardiac diseases in a timely fashion in the setting of preparticipation screening or medical consultation and provide appropriate advice regarding the participation in competitive sport activities and/or regular exercise programmes. Many asymptomatic (or mildly symptomatic) patients with cardiomyopathies aspire to participate in leisure-time and amateur sport activities to take advantage of the multiple benefits of a physically active lifestyle. In 2005, The European Society of Cardiology (ESC) published recommendations for participation in competitive sport in athletes with cardiomyopathies and myo-pericarditis. One decade on, these recommendations are partly obsolete given the evolving knowledge of the diagnosis, management and treatment of cardiomyopathies and myo-pericarditis. The present document, therefore, aims to offer a comprehensive overview of the most updated recommendations for practicing cardiologists and sport physicians managing athletes with cardiomyopathies and myo-pericarditis and provides pragmatic advice for safe participation in competitive sport at professional and amateur level, as well as in a variety of recreational physical activities.


Subject(s)
Cardiomyopathies , Leisure Activities , Myocarditis , Pericarditis , Sports , Cardiomyopathies/diagnosis , Cardiomyopathies/therapy , Humans , Myocarditis/diagnosis , Myocarditis/therapy , Pericarditis/diagnosis , Pericarditis/therapy , Risk Assessment
8.
Br J Sports Med ; 48(15): 1193-5, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24668047

ABSTRACT

Safe sports participation involves protecting athletes from injury and life-threatening situations. Preparticipation cardiovascular screening (PPS) in athletes is intended to prevent exercise-related sudden cardiac death by medical management of athletes at risk, which may include disqualification from sports participation. The screening physician relies on current guidelines and expert recommendations for management and decision-making. There is concern about false-positive screening results and wrongly grounding an athlete. Similarly, there is a concern about false-negative screening results and athletes participating with potentially lethal disorders. Who is legally responsible if an athlete suddenly dies after a proper PPS resulting in low risk? Several consensus documents based on expert opinion describe only a few lines on legal responsibilities in eligibility screening and disqualification decision-making in athletes. This article discusses legal responsibilities and concerns in eligibility decision-making for physicians.


Subject(s)
Death, Sudden, Cardiac/prevention & control , Sports Medicine/legislation & jurisprudence , Adolescent , Adult , Child , Decision Making , Early Diagnosis , Humans , Practice Guidelines as Topic , Professional Practice/legislation & jurisprudence , Social Responsibility , Young Adult
9.
Ned Tijdschr Geneeskd ; 156(31): A4895, 2012.
Article in Dutch | MEDLINE | ID: mdl-22853772

ABSTRACT

The sudden cardiac death (SCD) of an athlete is always a dramatic event, and one wonders if it could have been prevented by pre-participation cardiovascular screening. For years now, a pro/con debate has been taking place on the pre-participation screening of athletes: the method, who is responsible, cost-effectiveness, obligatory or voluntary screening. In this pro-article, which agrees with the "sudden cardiac death can be prevented by routinely pre-participation cardiovascular screening"-standpoint, the unique Italian experience is the best argument for the support of screening. This study clearly demonstrated a reduction in SCD in those athletes who were screened in accordance with Italian law.


Subject(s)
Athletes , Cardiomyopathy, Hypertrophic/diagnosis , Death, Sudden, Cardiac/prevention & control , Mass Screening/methods , Cardiomyopathy, Hypertrophic/complications , Cost-Benefit Analysis , Electrocardiography , Humans , Mass Screening/adverse effects , Mass Screening/economics , Medical History Taking , Physical Examination , Sports
10.
Eur Heart J ; 32(17): 2119-24, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21672932

ABSTRACT

Mass gathering events in sports arenas create challenges regarding the cardiovascular safety of both athletes and spectators. A comprehensive medical action plan, to ensure properly applied cardiopulmonary resuscitation, and wide availability and use of automated external defibrillators (AEDs), is essential to improving survival from sudden cardiac arrest at sporting events. This paper outlines minimum standards for cardiovascular care to assist in the planning of mass gathering sports events across Europe with the intention of local adaptation at individual sports arenas, to ensure the full implementation of the chain of survival.


Subject(s)
Death, Sudden, Cardiac/prevention & control , Emergency Medical Services/organization & administration , Health Planning/organization & administration , Sports , Cardiopulmonary Resuscitation/methods , Checklist , Communication , Defibrillators/supply & distribution , Emergency Treatment/methods , Equipment and Supplies , Health Personnel/education , Health Personnel/organization & administration , Humans , Interprofessional Relations , Medical Records , Quality of Health Care , Transportation of Patients
11.
Eur J Cardiovasc Prev Rehabil ; 13(5): 687-94, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17001206

ABSTRACT

The use of doping substances and methods is extensive not only among elite athletes, but also among amateur and recreational athletes. Many types of drugs are used by athletes to enhance performance, to reduce anxiety, to increase muscle mass, to reduce weight or to mask the use of other drugs during testing. However, the abuse of doping substances and methods has been associated with the occurrence of numerous health side-effects. The adverse effects depend on the type of the consumed drug, as well as the amount and duration of intake and the sensitivity of the body, since there is a large inter-individual variability in responses to a drug. Usually the doses used in sports are much higher than those used for therapeutic purposes and the use of several drugs in combination is frequent, leading to higher risk of side-effects. Among biomedical side-effects of doping, the cardiovascular ones are the most deleterious. Myocardial infarction, hyperlipidemia, hypertension, thrombosis, arrythmogenesis, heart failure and sudden cardiac death have been noted following drug abuse. This paper reviews the literature on the adverse cardiovascular effects after abuse of prohibited substances and methods in athletes, aiming to inform physicians, trainers and athletes and to discourage individuals from using drugs during sports.


Subject(s)
Cardiovascular Diseases/chemically induced , Doping in Sports/prevention & control , Adrenergic Agents/adverse effects , Adrenergic beta-Antagonists/adverse effects , Anabolic Agents/adverse effects , Central Nervous System Stimulants/adverse effects , Europe , Hormones/adverse effects , Humans , Narcotics/adverse effects
13.
Eur J Cardiovasc Prev Rehabil ; 13(2): 137-49, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16575266

ABSTRACT

BACKGROUND: Evidence for the proper management of ischemic heart disease (IHD) in the general population is well established, but recommendations for physical activity and competitive sports in these patients are scarce. The aim of the present paper was to provide such recommendations to complement existing ESC and international guidelines on rehabilitation and primary/secondary prevention. DESIGN AND METHODS: Due to the lack of studies in this field, the current recommendations are the result of consensus among experts. Sports are classified into low/moderate/high dynamic and low/moderate/high static, respectively. RESULTS: Patients with a definitive IHD and higher probability of cardiac events are not eligible for competitive sports (CS) but for individually designed leisure time physical activity (LPA); patients with definitive IHD and lower probability of cardiac events as well as those with no IHD but with a positive exercise test and high risk profile (SCORE > 5%) are eligible for low/moderate static and low dynamic (IA-IIA) sports and individually designed LPA. Patients without IHD and a high risk profile+ a negative exercise-test and those with a low risk profile (SCORE < 5%) are allowed all LPA and competitive sports with a few exceptions. CONCLUSIONS: Individually designed LPA is possible and encouraged in patients with and without established IHD. Competitive sports may be restricted for patients with IHD, depending on the probability of cardiac events and the demands of the sport according to the current classification.


Subject(s)
Cardiology/methods , Exercise , Leisure Activities , Myocardial Ischemia/prevention & control , Myocardial Ischemia/rehabilitation , Sports , Adult , Aged , Cardiology/standards , Coronary Artery Bypass/rehabilitation , Female , Humans , Male , Middle Aged , Myocardial Ischemia/physiopathology , Risk Assessment
14.
Heart Rhythm ; 2(10): 1058-63, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16188581

ABSTRACT

BACKGROUND: Asynchronous activation resulting from right ventricular apical (RVA) pacing can adversely affect left ventricular function and myocardial perfusion despite normal coronary arteries. This situation makes detection of coronary heart disease in paced patients difficult. OBJECTIVES: The purpose of this study was to assess the distribution, extent, and severity of myocardial perfusion defects with RVA pacing at low and high rates and increased coronary blood flow with adenosine. METHODS: Fourteen patients with permanent RVA pacing and angiographically normal coronary arteries underwent myocardial perfusion single-photon emission computed tomography at rest at low and high pacing rates and with pacing at low rates with adenosine. Data were analyzed semi-quantitatively using a 20-segment scoring model and coded using a four-point scoring system. RESULTS: At rest, 23 (55%) of 42 coronary flow territories showed abnormal perfusion and 52 (19%) of 280 corresponding segments demonstrated abnormal perfusion; mean perfusion score was 0.22. After high-rate pacing, perfusion was abnormal in 31 (74%) of 42 flow territories and 122 (44%) of 280 segments; mean perfusion score was 0.67. Adenosine infusion resulted in 28 (67%) of 42 abnormal flow territories and 90 (32%) of 280 abnormal segments; mean perfusion score was 0.44. Perfusion defects were observed most often in close proximity to the origin of the pacing site. CONCLUSION: RVA pacing results in myocardial perfusion defects. The false-positive findings are present at rest and more obvious with high-rate pacing than during adenosine infusion. Detection of coronary artery disease should be performed with caution in RVA paced patients because of the high number of perfusion defects observed in the absence of coronary artery disease.


Subject(s)
Cardiac Pacing, Artificial , Myocardial Reperfusion Injury/etiology , Pacemaker, Artificial/adverse effects , Adenosine/administration & dosage , Anti-Arrhythmia Agents/administration & dosage , Blood Pressure/drug effects , Blood Pressure/physiology , Coronary Circulation/drug effects , Coronary Circulation/physiology , Heart Rate/drug effects , Heart Rate/physiology , Heart Ventricles/drug effects , Heart Ventricles/physiopathology , Heart Ventricles/surgery , Humans , Intraoperative Complications/etiology , Intraoperative Complications/physiopathology , Myocardial Reperfusion Injury/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...